Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
13. Oct 2026 / 08:15 CET/CEST, transmitted by GlobeNewswire.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
Name |
Leo International Precision Health Aktiengesellschaft |
Street address |
Am Klopferspitz 19 |
Postal code |
82152 |
City |
Planegg Martinsried |
LEI |
529900R5095181VD8H48 |
2. Reason for notification
Acquisition/disposal of shares with voting rights |
3. Details of person subject to the notification obligation
Natural Person
Name |
Birth date |
|---|---|
Hsiao-Hsuan Wang |
03.08.1978 |
4. Name(s) of shareholder(s) holding directly 3% or more voting rights, if different from details of person subject to the notification obligation
Name |
|---|
SGCI Corporate Finance GmbH |
5. Date on which threshold was crossed or reached
02.10.2026 |
6. Total positions
% of voting rights attached to shares (total of details on total positions 7.a.) |
% of voting rights through instruments (total of details on total positions 7.b.1. + 7.b.2.) |
Total of both in % (details on total positions 7.a. + 7.b.) |
Total number of voting rights pursuant to Sec. 41 WpHG |
|
|---|---|---|---|---|
New |
69.87% |
0.00% |
69.87% |
106,560,000 |
Previous notification |
84.20% |
0% |
84.20% |
- |
7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN |
Absolute |
In % |
||
Direct (Sec. 33 WpHG) |
Indirect (Sec. 34 WpHG) |
Direct (Sec. 33 WpHG) |
Indirect (Sec. 34 WpHG) |
|
DE0005490601 |
70,570,840 |
3,885,000 |
66.23% |
3.65% |
Total |
74,455,840 |
69.87% |
||
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Voting rights absolute |
Voting rights in % |
|---|---|---|---|---|
0 |
0.00% |
|||
Voting rights absolute |
Voting rights in % |
|||
Total |
0 |
0.00% |
||
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Cash or physical settlement |
Voting rights absolute |
Voting rights in % |
|---|---|---|---|---|---|
0 |
0.00% |
||||
Voting rights absolute |
Voting rights in % |
||||
Total |
0 |
0.00% |
|||
8. Information in relation to the person subject to the notification obligation
X |
Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer |
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity |
9. In case of proxy voting according to Sec. 34 (3) WpHG
Date of general meeting
Total positions (6.) after general meeting:
% of voting rights attached to shares |
% of voting rights through instruments |
Total of both |
|---|---|---|
10. Other useful information
3.885.000 Stimmrechte der SGCI Corporate Finance GmbH, Frankfurt am Main, werden dem Meldepflichtigen aufgrund einer Verhaltensabstimmung gemäß § 34 Abs. 2 WpHG wechselseitig zugerechnet. |
Date
08.10.2026 |
End of message
GlobeNewsWire Distribution Services include regulatory announcements, financial/corporate news and press releases.
Archive at www.globenewswire.com
Language |
English |
Company |
Leo International Precision Health AG |
Am Klopferspitz 19 |
|
82152 Planegg / Martinsried |
|
Germany |
|
Internet |
https://www.liphag.com |